Try our Advanced Search for more refined results
Health - February, 2022
384 articles
- Flint Water Engineers Were 'Puzzle Pieces' Of Crisis, Jury Told
- Endo, Arnold & Porter Opioid Discovery Called 'Truly Awful'
- Mylan Inks $264M Deal Ending EpiPen Class Price-Hike Suit
- Anthem Must Face ERISA Suit Over Mental Health Coverage
- Abortion Rights Bill Fails In Senate As Roe's Future In Limbo
- The Battle To Confirm Ketanji Brown Jackson
- Chicago Firm Files Class Actions Over Medical Records Costs
- Hartford HealthCare Looks To Toss Antitrust Suit
- Smith & Nephew Gets Claims Trimmed In Hip Implant MDL
- GOP Sens. Ask HHS To Nix 'Toxic' Bid To Seize Cancer Drug IP
- Cravath, Goodwin Pilot Viatris' Up To $3.34B Biosimilars Deal
- Opana Buyers Want Pay-For-Delay Trial Split In 3
- 2 More SPACs Pull IPOs Totaling $400M As Withdrawals Mount
- Texas Justices Nix Early Discovery In Medical Malpractice Suit
- 3rd Circ. Preview: March Roars With Ch. 11, Poaching Spats
- Ex-Worker Says Amazon's Health Benefit Notices 'Threatening'
- Bankrupt Stem Cell Biz To Pay $3.65M In Class Settlement
- Bankruptcy Is Optimal Venue For Mass Tort Cases
- Hunton, McDermott Shape $18B Merger Of Health Care REITs
- Party Leaders Vow Open Minds For New High Court Pick
- Sutter Exec Pressed On COVID Care In $411M Antitrust Trial
- DOJ Has Few Allies, Many Foes In High Court Opioid Brawl
- How Judge Jackson Beat Out Competition For High Court Nod
- Why Ketanji Brown Jackson Honored This Historic Judge
- 1st Circ. Judge Selya Says Jackson Will Be 'Balanced'
- Edited Med Mal Claims Can Still Trigger Texas Expert Deadline
- Cannabis Bill Roundup: Legalization Bids Advance In SD, Md.
- Zetia Buyers Get Narrow Market In Generic-Delay Suit
- 1st Circ. Revives Medical Malpractice Suit Over Court Error
- Brand Battles: BetterUp Takes Aim At 'BetterHelp' Trademark
- UnitedHealthcare Must Revisit Mental Health Claim Denials
- Litigator Makes Move From Bartlit Beck To Winston & Strawn
- Stericycle Takes $81M Hit On Bribery Deal With DOJ, SEC
- Biden's Supreme Court Pick Was Star Debater In Miami
- The Key To Turning Solid Briefs Into Winning Briefs
- What's At Stake In Doctors' Opioid Liability Case In High Court
- Generic-Drug Maker Takes Novartis Battle To Full Fed. Circ.
- ABI Panelists, US Chamber Support Ch. 11 3rd-Party Releases
- J&J, Drug Distributors' $26B Opioid Settlement Is Finalized
- The Big Picture: COVID Coverage Cases In Fed. Appeals Court
- J&J Talc Unit's Ch. 11 Case Allowed To Go Forward
- 6 Judge Ketanji Brown Jackson Opinions To Read Now
- Biden Nominates Judge Ketanji Brown Jackson To High Court
- Bill Paxton's Family Inks $1M Deal With Anesthesia Group
- Ga. County Likely Can't Avoid Trial In Trans Deputy's Bias Suit
- Hartford Unit Beats Dental Office's COVID-19 Coverage Claims
- Anthem BCBS Gets Trans Worker's Discrimination Suit Tossed
- Teligent Says Stalled Plan Talks Make Liquidation Best Option
- Biden Seeks To Boost Domestic Production In New Plan
- UK Finance Minister Wants To Cut Taxes, Resist Intervention
- Atty's Improper Closing Voids Hospital Win In Infant Care Trial
- Steps For Universities As DOJ Shifts Foreign Influence Policy
- FDA Commits To Compounding Drug Rulemaking
- Calif.'s Top Court OKs Med Mal Cap, Slashed $4.3M Award
- Health Workers Can't Get Freeze On NY Vaccine Mandate
- UnitedHealth Unit Pays $5.8M To End Mass. Drug Price Probe
- SDNY Mootness Fee Refusal May Shake Up A Common Tactic
- Texas Can Break With High Court On Abortion Law, State Says
- Ex-Patriots Player, Feds Strike Restitution Deal In COVID Scam
- Medtronic Can't Shake Illegal Kickback Suit
- Indian Health Care Biz MediBuddy Lands $125M In Funding
- Racehorse Trainer Snared In Doping Scandal Gets 3 Years
- DOJ Challenges UnitedHealth's $13.8B Change Deal
- Texas Judge Rejects HHS Rule On Surprise Medical Billing
- Sutter's Market Dominance Hiked Premiums $411M, Jury Told
- Telehealth Fraud Not An Easy FCA Target, DOJ Attys Say
- Trade Org Urges Gov't Action On Hemp-Derived Intoxicants
- NM Justices Turn Down Petition, Let Medical Pot Stay Untaxed
- Optum And Oxford Win Drug Pricing ERISA Suit
- Pfizer Drops Case Alleging Ex-Employee Stole Pharma Data
- Pandemic Deemed No Excuse For Late Med Mal Expert Filing
- Texas Court Debates Discretion In Periodic Payment Awards
- Asarco Wins Toss Of Retiree Health Benefits Class Action
- Walgreens, Drugmakers Can't Get Stay In Opioid Bellwether
- How Health Care Cos. Can Prepare For DOJ's Cyberfraud Push
- Del. Judge Says No Break For Insurer On $5M Settlement Error
- Va. Medical Center's Virus Coverage Suit Survives
- US Says Gulf Coast Unclear On Fate Of Pandemic Payments
- 9th Circ. Orders BIA To Revisit Mexican's Abuse Claims
- Sutter Dominated Market; Employers Wanted It, Jurors Hear
- Valeant Judge OKs $23M To End 'Secret' Pharmacy RICO Suits
- Maker Of Recalled COVID-19 Tests Accused Of False Labeling
- MyChart Maker Wants Protection From NPE's Patents
- 9th Circ. Boots COVID-19 Death Suit Back To Calif. State Court
- Pa. Court Says Man Can't Pin Tardy Med Mal Suit On Pandemic
- Patient Death Suit Partially Restored Against Mass. Hospital
- High Court Asks DOJ For Opinion On Medical Pot Payments
- Costco Reaches Deal To End COBRA Notice Language Suit
- Stryker Must Face FCA Claim In Medical Device Fraud Suit
- Health Co. Asks High Court To Rein In FCA Pleading Rules
- Self-Evaluative Privilege May Protect Internal Investigations
- UnitedHealth And Change Say Time's Up For DOJ Deal Review
- Texas Doctor Can't Escape Death Suit Over Missed Blood Clot
- Charities Ensnared In NJ Antitrust Suit Over Cancer Drugs
- Nursing Home Co. Must Face Firing Suit Over $3M Refunds
- Justices Won't Review Maine Health Care Worker Vax Mandate
- Dental Clinic Seeks State Review In 2nd Circ. Virus Appeal
- Deciphering Group Health Plan Disclosure Rules Under ERISA
- Hospital Board Says IHS 'Scrambling' To Quell Contract Row
- Sutter's Practices Raised Premiums For SF Workers, Jury Told
- BlackRock Pens Tribute To CRO, And Other People Moves
- NJ Medical Pot Hopefuls Say Agency Snubbed Court Ruling
- Dr. Asks 9th Circ. To Restart DaVita Unnecessary Care Suit
- Cannabis Bill Roundup: Legalization Bids In The Heartland
- J&J Talc Unit Says Ch. 11 Only Recovery Option For Claimants
- NJ Health System Aims To Toss Breach Suit Over ER Contract
- DC Circ. Is Urged To Greenlight COVID-19 Death Suit
- Prenatal Defect Test Maker Hit With Suit Over False Positives
- Texas Jury Orders Health Center To Pay $2.7M In FCA Case
- 6th Circ. Ends Suits Challenging OSHA's Vax-Or-Test Rule
- Walter Dellinger's Little-Known, Outsize Impact On Legal Aid
- Health Hires: Horizon Therapeutics, Zynerba
- B. Braun Class Cert. Will Await 3rd Circ. ERISA Ruling
- Union Sues Die Cast Manufacturer Over Absent Health Plans
- Trainer In Horse Doping Scheme Deserves 3 Years, Feds Say
- Clark Hill Health Care Atty Joins Waller Lansden In Austin
- Sacklers Offer Another $1.6B For Purdue Ch. 11 Settlement
- FCC Floats $45M Fine Against Health Insurance Robocaller
- Ex-Sutter CFO Denies Flexing Market Muscle At Antitrust Trial
- Talc Claimants Say J&J Unit's Ch. 11 Benefits Parent Co. Only
- Old Settlements Doom Some Doctors' BCBS Antitrust Claims
- DOD Wants 5th Circ. To Narrow Injunction In COVID Vax Case
- 7th Circ. Asked To Revive FCA Suit Over Cook County Grants
- FTC, Rhode Island AG Move To Block Hospital Merger
- Attys From Four Firms Named To Co-Lead Philips CPAP MDL
- Nurse, Marine Reservist Charged With Selling Fake Vax Cards
- Why I'll Miss Arguing Before Justice Breyer
- How Investors Can Navigate A Vibrant Digital Health Market
- Amid Historic Spending, Congress Should Strengthen FCA
- Medicare Fraud Conspiracy Case Beats Trial Delay Challenge
- Judge Axes HHS Letter Over AstraZeneca Discount Dodging
- Australian Condom Co. Takes 'Naked' TM Fight To Court
- SG Tells Justices To Skip Review Of $420M Trade Secrets Row
- Castlight Investor Sues In Del. To Probe $370M Vera Deal
- Insurer Fights Minn. Dentist's 5th Circ. Virus Coverage Appeal
- Calif. Nursing Home Can't Arbitrate Patient Death Suit
- 5th Circ. Backs Workers Fighting United Airlines Vax Mandate
- NY Cannabis Regulators Approve New Medical Pot Rules
- Purdue Gets OK For 2-Week Opioid Suit Freeze Extension
- New 'Public Charge' Rule Excludes Noncash Benefits
- Invisalign Must Face Fed Antitrust Claims, Some State Claims
- Endo Urges Opioid Judge's DQ For 'Egregious' Ethics Lapses
- Pfizer Prevails In Proposed Class Action Over Chantix Recall
- FTC, Weight Loss Co. Ink Deal To Safeguard Kids' Privacy
- Ex-VA Health Official Questions Sutter Costs At Antitrust Trial
- 3rd Circ. Revives Aetna's Bid To Seal Docs In Hospital Suit
- '150 Billion Pills' Gaffe Imperils NY AG's Opioid Win Over Teva
- Tesla, Comcast, Dell, Mylan Join Tech Cos. In Fighting Fintiv
- Texas Sues Biden Over Air Travel Mask Mandate
- Ohio Hospital Must Produce Doctor's File In Malpractice Suit
- Ex-Pharma CEO Wants Landmark Opioid Conviction Tossed
- Calif. Gets Pay-For-Delay Ban Partially Revived
- Air Force Can't Make Unvaccinated Ga. Officer Retire
- What Cos. Can Learn From The 2021 FCA Recovery Statistics
- Calif. Says Oakland Pollution Impacts Black, Latino Health
- Austrian Pharma Co.'s €142M Award Nixed In Germany
- Pension Fund Sues For Docs On $23.8B Cerner-Oracle Deal
- Suit Claiming NJ Atty Botched Med Mal Case Sent To Mediator
- Cities, Tribes, Schools Fight Toss Of McKinsey Opioid MDL
- DOL Sues Pa. Home Care Company, Charging Wage Violations
- UnitedHealth Wants High Court Review Of Medicare Rule
- DOJ Pans Glenmark 'Fishing Expedition' For Grand Jury Docs
- Recent Rulings Show Lawyer Criticism Of Judges Is Perilous
- Ch. 11 For J&J Talc Unit Only Wise Choice, Top Lawyer Says
- Sutter's Prices 'Difficult To Justify,' Antitrust Jury Hears
- DOJ Fraud Section Roars Back From Pandemic Conviction Dip
- 'Failed Experiment' Licensing Not Irrational, 6th Circ. Says
- Med Co. Trims But Can't Ax Spinal Implant Patent Suit
- Texas Doc Must Face Suit Over 7-Year-Old Boy's Injured Eyes
- House Dems Push Biden Admin. To Justify Migrant Expulsions
- Takeaways From DOJ Fraud Section's 2021 Year In Review
- McGuireWoods Adds Ex-BakerHostetler Health Atty In Atlanta
- CVS Wants Consolidated Drug Pricing Suit In Arbitration
- Medline Seeks End To Hartford's Libel Suit Coverage Fight
- Breyer's Role In Courthouse Design Sets A Judicial Template
- In Close Vote, Senate Confirms Califf To Head FDA
- Abrams Fensterman Adds Criminal Defense Group Chair
- Sutter Hospitals Forced On Insurers, Antitrust Trial Jurors Told
- Fla. Health System To Pay $5.5M For Barred Medicaid Funding
- Endo Opioid Saga 'Like A John Grisham Movie,' Judge Says
- Talc Claimants Argue Bad Faith In J&J Unit's Ch. 11 Trial
- Lab Owners Must Face $24M Medicaid Overpayment Claims
- Contractor, Investors Reach $3.3M Deal In COVID Tests Suit
- Tribal Hospital Sues Gov't For Cutting Funding By 90%
- Okla. Rolled Out Medical Pot Too Quickly, Watchdog Finds
- Ark. Pot Cos. Say State's New Rules Are Unconstitutional
- Mallinckrodt Seeks Last Extension Of Ch. 11 Acthar Suit Pause
- Pacific Life Loans $260M For Philly Project
- Expect Aggressive Life Sciences Enforcement In 2022
- All But 2 Claims Trimmed In Pa. Pelvic Mesh Case
- Hotel Group Urges High Court To Kill Seattle Benefits Law
- Pfizer Hits Teva With Suit Over Arthritis Drug Patent
- Bioness Stockholders Challenge $110M Sale To Bioventus
- Real Estate Rumors: Moskovits, GL Homes, AccentCare
- California Biotech Co. Appoints 1st General Counsel
- Pa. AG Says Philadelphia Vaccine Nonprofit Must Dissolve
- TeamHealth To Pay $15M To End Doctor Bonuses Suit
- Alcoa Retirees Want Class Status In Lifetime Benefits Suit
- Ky. Hospital Can't Escape Death Suit Over Wrong CT Scan
- 5 Key Details As Endo Is Rocked Again By Opioid Default
- FDA Won't OK Pfizer's Under 5 Vax Until 3-Shot Study Is Done
- Sutter Exec Defends Contract Terms In $411M Antitrust Trial
- Taiwanese Pharma Co. Says €142M Award Can't Be Enforced
- Fed. Circ. Upholds J&J's Win In Surgical Tool IP Fight
- Cannabis Bill Roundup: A Cure For Hemp's THC Headaches?
- 3rd Circ. Sees Case Law Disfavoring ERISA Class Cert. Appeal
- 7th Circ. Sides With Gov't In Suit Over Post-Surgery Death
- 4 Emerging Trends To Watch In COVID-19 Fraud Enforcement
- What Happened In Flint: Trial To Pull Back Curtain On Crisis
- Feds' Bid To Pause Block On Workers' Vax Mandate Denied
- FTC Mulls Asking PBM To Probe Effects On Competition
- FTC No Longer Pressing For Caris Docs In Illumina Case
- Health Hires: Reed Smith, McGuireWoods
- 10th Circ. Revives Call Center Worker's Bias Suit
- Texas Cardiologist Wants Hospital's Antitrust Claims Tossed
- DC Circ. Affirms FCC's Expanded Wireless Antenna Rules
- Sober Home's Medical Chief Convicted Of $110M Billing Fraud
- Law Professors Say J&J Talc Ch. 11 Is Shielding Assets
- 2 Firms Get $12.2M For $45M Surgery Partners Suit Settlement
- Endo Hit With New Default Ruling In Opioid Discovery Debacle
- Walgreens OK'd To Pursue Crowell & Moring Breach Claims
- Wash. Lays Out $38B Opioid Abatement Plan To Trial Judge
- Sutter's Anti-Competitive Tactics 'Gouge' Clients, Jury Hears
- Astellas Workers Win Class Cert. In Suit Over 401(k) Losses
- J&J Unit Says Ch. 11 Is Best Response To Talc Suit 'Tsunami'
- Fla. Clinics Can't Ditch Gilead's HIV Drug Charity Scam Claims
- 5th Circ. Grants New Trial Over Sanofi Chemo Drug
- Cook County Signs Off On $6.75M Med Mal Deal
- Clinic Dodges $50M Punitive Verdict In $7.6M Ga. Judgment
- Expert Report Defects Doom Pa. Patient Death Suit
- Nursing Home Biz Gets Nod For Ch. 11 Facility Sale Plans
- GAO Says CMS Improperly Combined $27M Contract Bids
- Aetna Ordered To Pay More For Mental Care In ERISA Suit
- J&J Can't Be Allowed To Dodge Civil Justice With Bankruptcy
- Norton Rose Nabs Health Care Pros From Morgan Lewis
- 3M Wants High Court Look At Surgical Blanket Expert Ruling
- Ruling Highlights Key Intersection Of 2 Health Benefit Laws
- NY Court Revives Suit Over ER Patient's Fatal Hemorrhage
- Boston Hospitals Say Vax Rule Must Survive 1st Circ. Review
- Split 5th Circ. Won't Stay Block Of Fed. Worker Vax Mandate
- Ex-NFL Player, Health Plan Fraud 'Ringleader' Gets 5 Years
- Mo. Justices Say Winning Pot License Applications Are Public
- Fed. Circ. Says Army Corps Must Pay Specified Bank Account
- Texas Wants National Guard Vaccine Mandate Halted
- SmileDirect Judge Won't Pause Slow-Moving Antitrust Case
- Racehorse Trainers, Vet Can't Dump Doping Scheme Charges
- Groups Urge Biden Admin. To Halt New Gulf Oil Exploration
- Workers In Calif. Eligible For Paid COVID Time With New Law
- Blood Filter Co. Can't Withhold Financial Records In Mass Tort
- Big Names Join COVID Coverage Fights In Turning Point
- Zetia Buyers Defend Class Cert. As 'Common Business Sense'
- Hospital Says Insurer's Settlement Suit Belongs In State Court
- Suit Says Aetna's Fertility Treatment Policy Is Discriminatory
- Greenberg Traurig Adds Shareholders To LA Corporate Group
- Real Estate Rumors: Terra, Bison, WeWork
- NY Judge OKs Canadian Entities' Late Purdue Ch. 11 Appeal
- Medtronic Can't Ditch All Claims In Faulty Pacemaker Suit
- 2 FTC Settlements Guide On Consumer Review Best Practices
- BigLaw Must Nix All-Or-Nothing Work Model To Retain Talent
- Cooperator In Meningitis Outbreak Case Gets Time Served
- New FCA Stats Fuel Debate Over Health Enforcement Fixation
- Feds Fight Alford Plea For Ex-Prof Accused Of Insider Trading
- Maine's Pot Residency Rule Unconstitutional, 1st Circ. Told
- Court Boots Mootness Fee Bid In Microsoft Merger Challenge
- Opioid Crisis In Wash. State 'Unique,' Judge Told
- Lost Theranos Data 'Paints Picture Of Deception,' Judge Says
- Senators Hear Possible Solutions To 'Texas Two-Step' Issues
- FSD Pharma Says Delaware Suit Belongs In Ontario
- DOJ Wants To Build On DaVita Win In No-Poach Cases
- Fla. Justices Mull Medicare Expenses Math In Injury Suits
- Univ. Of Calif. To Pay $244M To End Doctor Sex Abuse Claims
- Sun Pharma, Lupin Agree To Drop Eye Pain Patent Dispute
- Ohio Justice Likens Virus Coverage Issue To Fogged Mirror
- Compliance Hires Of '22 Reflect US Cyber, Corruption Focus
- Canadian Entities Seek Late Appeal In Purdue Ch. 11 Case
- Oracle Gives DOJ More Time To Review $28B Cerner Deal
- Biogen Hid Issues With Alzheimer's Drug, Investor Suit Claims
- Biden's Supreme Court Nominee Should Have 5 Key Qualities
- Distributor Can't Get Coverage For Missing Medical Equipment
- GM Slapped With Class Action Over Benefits Notices
- Using Insurance Coverage To Fund Early Settlement
- Teligent Lender Slams Creditor Group Bid To Claw Back Cash
- 1st Circ. Spots 'Gap' In Cancer-Drug Suit Against Karyopharm
- Ex-Spine Doc Owes $13M To Women Over Faulty Surgeries
- Harvard Prof Says China-Ties Conviction Too Flimsy To Stand
- Calif. Lawmakers OK More Paid COVID Leave For Workers
- J&J Drops Bid To Block Reuters Story As Attys Trade Barbs
- Sutter Antitrust Jurors Will Be COVID-19 Boosted, Judge Says
- Generics Co. Accuses Ex-Exec Of Swiping Trade Secrets
- FDA Probing Possible Death Risk Of Lymphoma Drug
- Engineering Co. Can't Escape Flint Water Negligence Claim
- Inside The New Guidance On Federally Funded Research
- 3rd Circ. Rejects Rehearing Bid In COVID Death Suits
- Minn. Bill Seeks Subtraction Of Health Providers' Virus Aid
- Airline Group, San Francisco Spar Over Health Care Ordinance
- Texas Strikes $225M Deal With Teva Over Opioid Crisis
- AstraZeneca, Merck Want Calquence Generics Halted
- Colo. Bill Would Allow Deduction For Medical Costs
- Law360 Seeks Members For Its 2022 Editorial Boards
- Boston Teachers Sue Over Denied Remote Work In Pandemic
- Flint Residents' Attys Awarded $39.6M As Part Of Water Deal
- Ex-Theranos Exec Seeks To Block Holmes Trial Evidence
- Reuters Says J&J Too Late To Nix Story Over Atty Leak Claim
- Health Provider Says Rival Funded TCPA Suit To Seize Market
- Insurer Can't Fully Escape Clinic's $150M Virus Coverage Suit
- Anesthesiology Group Puts To Rest Drugmaker's Libel Suit
- Cannabis Bill Roundup: SAFE Banking Passes House — Again
- UnitedHealth Units Beat ERISA Drug Overcharge Claim
- Payment Co. Founder's Rant May Not Cost Him $27M After All
- Shkreli's Lifetime Pharma Ban Upheld
- Connecticut Hospital Can't Undo $3.2M Verdict In Injury Suit
- Gulf Coast Asks To Hand Over One Of Last Facilities In Ch. 11
- EU Suspends Deadline For Illumina's $8B Grail Deal
- 7th Circ. Axes Sexual Assault Suit Against Chicago Paramedic
- Biden Extends Pandemic Border Block Amid Legal Challenges
- Final Approval In Glumetza Antitrust Deal Gives Attys $50M
- 2 Recent Decisions Highlight Ambiguity As FCA Defense
- Policyholder Attys Eye Ohio Justice's Role In COVID-19 Fight
- Lawyer Wants To Arbitrate NFL Player's Billing Dispute
- Ex-NECC Execs Seek New Trial After Revived Convictions
- Miles & Stockbridge Health Care Team Adds Principal
- Feds Say J&J Talc Trust Can't Exclude Medicare Claims
- Purdue Asks For New Extension On Opioid Suit Freeze
- Anthem Wants Ga. Justices To Step Into Contract Fight
- Philly, Pittsburgh DAs Lose Bid To Stop Opioid Settlement
- Mallinckrodt Ch. 11 Plan Gets Green Light From Del. Court
- J&J Says Talc Plaintiff Attys Fed Confidential Docs To Reuters
- Opioid Trial In Wash. State Briefly Interrupted For Evacuation
- Lack Of ID Theft Dooms Medical Data Breach Suit, Judge Says
- Calif. Judge Unpersuaded To Nix Drugmakers' Opioid Trial Win
- Ex-UChicago Prof Seeks Alford Plea Over Insider Trades
- DaVita Subsidiary Sues Landlord Over Unsafe Philly Building
- Texas Justices Consider Doc's Liability In Teen Suicide Case
- 7th Circ. Scolds VA For 'Runaround' In Worker Malpractice Suit
- UnitedHealth Workers Win Class Cert. In ERISA Suit
- Scholar Briefs OK'd In J&J Talc Unit's Ch. 11 Dismissal Bid
- Upcoming Rulings Key To Defining PREP Act Protections
- Texas Justices Told Blue Cross Can't Get $3M Tax Refund
- GAO Says VA Reasoning Was Sound In $735M IT Deal
- Vision Center And Owner Remain In Pared Down FCA Suit
- Hospital Shooting Suit Not Blocked By NY Workers Comp Law
- Judge Ordered DOJ Atty To Remove Mask, Watchdog Says
- Lifetime Ban For Shkreli Means Lifetime Ban, FTC Says
- Summer Trial Teed Up For Atty Accused Of $8M Escrow Fraud
- Deals Rumor Mill: Novartis, Cedar Fair, IVI-RMA
- NFL Health Plan Fraud 'Ringleader' Faces Up To 9 Years
- Health Care Group Of The Year: Williams & Connolly
- Mississippi Legalizes Medical Pot After Governor's Signature
- BCBS Unit's $28M Shkreli Deal Poised For Initial OK
- Feds Sue Hawaii Health Dept. Over Fuel Storage Order
- Drug Distributor Stymied On FDA Topics In Wash. Trial Cross
- Hawaiian Airlines Workers Can't Block Vaccine Mandate
- Florida Governor Exits Challenge To Ban On Trans Athletes
- Feds Charge 4 In Death Of 'The Wire' Actor Michael K. Williams
- Glenmark Wants Grand Jury Evidence In Price-Fixing Case
- JPML Sends False Ad Suits Over Sleep Device Cleaners To Pa.
- Biden Nominates Michigan District Judge To 6th Circ.
- 5th Circ. Urged To Revive Texas' School Mask Mandate Ban
- Ex-Drug Co-Op CEO Convicted In Landmark Opioid Case
- Pfizer Says Ex-Execs Swiped Data For Rival Drug Startups
- The Flaws In The Traditional Approach To Hiring A Law Firm
- Taxotere Eye Damage Suits Consolidated In Louisiana MDL
- Gerber Accused Of Cutting Anti-Competitive Deal With Perrigo
- Health Care Group Of The Year: Sheppard Mullin
- Man Gets 2nd Shot At Death Suit After Atty Ditches Firm
- Latham-Led Great Hill Lands $4.7B For Latest Fund
- Novartis Ducks Regeneron's Antitrust Countersuit To IP Fight
- How Rx Drugs Become Illegal Street Sales Murky, Judge Told
- At Fed. Circ., Novartis Rips Amgen's 'Patent Estate'
- Shkreli Fights Scope Of Pharma Industry Ban
- UPMC Says Hospital Does Not Owe More To Pension Fund
- 1st Circ. Revives Most Of Raytheon Benefits Denial Suit
- High Court Urged To Take Up Medical Pot Reimbursements
- DOJ Recovers $5.6B In 2021 For 2nd-Highest FCA Haul
- Pfizer Wants FDA's Approval Of COVID Vax For Kids Under 5
- Feds Secure Plea In 1st COVID-19 Health Provider Fraud Case
- Law360's Tort Report: Whitey Bulger Death Suit Thrown Out
- Calif. Single-Payer Health Care Tax Package Dead For Now
- Hospital Can't Avoid Suit Over Harvest Of Daughter's Organs
- GAO Nixes IT Co.'s Protest Of $26M Health Agency Contract
- Purdue Closing In On New Ch. 11 Deal With Sackler Family
- 7th Circ. Rejects UnitedHealth's Class Certification Appeal
- Health Care Group Of The Year: Ropes & Gray
- Tribes Reach $590M Opioids Deal With J&J, Distributors